中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:( Shuxiang HAN)

1.Clinical Significance of Measurement of Urinary Leukotrience E_4 (LTE_4) in Patients with Asthma.

Yanhong CUI ; Shuxiang HAN ; Minghui WANG

Journal of Medical Research 2006;0(02):-

2.Clinical efficacy of otolith-repositioning maneuver combined with medical treatment on benign paroxysmal positional vertigo in the elderly patients

Qian HAN ; Shuxiang ZHANG ; Hongyan YUAN ; Ping LIU ; Yaping YAN

Chinese Journal of Geriatrics 2015;34(5):543-545

3.Clinical characteristics and observation of curative effect of benign paroxysmal positional vertigo after sudden hearing loss

Hongyan YUAN ; Shuxiang ZHANG ; Yaping YAN ; Qian HAN

Chinese Archives of Otolaryngology-Head and Neck Surgery 2016;23(2):78-80

4.Synergistic effect of acupuncture and human amniotic mesenchymal stem cell transplantation on the treatment of osteoporosis in ovariectomized rats

Yumin CHEN ; Taoping CHEN ; Cuiyu HAN ; Tonghuan SHI ; Shuxiang DONG

Chinese Journal of Comparative Medicine 2016;26(10):43-49

5.Path Analysis of Related Factors to Quality of Life among Rural Elderly People in Shandong Province

Rui JING ; Xiangyun LI ; Xiaodong LIU ; Shuxiang YANG ; Liantang HAN

Chinese Mental Health Journal 2002;0(12):-

6.Care bundles in the management of nasal intestine for the cerebral apoplexy patients with dyspinic dysfunction

Mei HAN ; Xiujuan XUE ; Chuanyao DENG ; Shuxiang ZHANG

Chinese Journal of Practical Nursing 2018;34(26):2017-2021

7.Short-term efficacy and safety analysis of PD-1 inhibitor combined with SOX neoadjuvant therapy for locally advanced gastric adenocarcinoma

Tao WANG ; Lulu ZHANG ; Shuxiang DU ; Han ZHANG ; Longfei MA ; Gang WU ; Peichun SUN

Tumor 2023;43(8):635-645

8.Study on the Subject M ining and Quantitative Evaluation o f Biomedical Industry Policy in National High-tech Industrial Development Zone

Han QIAO ; Liying XU ; Xu LI ; Shuxiang LI ; Shuzhen CHU

China Pharmacy 2020;31(22):2689-2694

9.Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.

Yuankai SHI ; Ping ZHOU ; Xiaohong HAN ; Xiaohui HE ; Shengyu ZHOU ; Peng LIU ; Jianliang YANG ; Changgong ZHANG ; Lin GUI ; Yan QIN ; Sheng YANG ; Liya ZHAO ; Jiarui YAO ; Shuxiang ZHANG

Chinese Journal of Cancer 2015;34(11):522-530

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO